COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19
For less-sick patients, results from the ACT trials showed no benefits with colchicine, aspirin, or rivaroxaban plus aspirin.
Source: tctmd.com
Stay updated with breaking news from Alida Caforio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For less-sick patients, results from the ACT trials showed no benefits with colchicine, aspirin, or rivaroxaban plus aspirin.
But is it worthwhile without a mortality benefit? Trials present complex picture